The effect of growth hormone adjuvant therapy on assisted reproductive technologies outcomes in patients with diminished ovarian reserve or poor ovarian response

S Dogan, OSY Cicek, M Demir, L Yalcinkaya… - Journal of gynecology …, 2021 - Elsevier
Low response of patients with diminished ovarian reserve to exogenous gonadotropins in
controlled ovarian stimulation (COS) protocols is one of the important problems of …

[HTML][HTML] Growth hormone cotreatment for low-prognosis patients according to the POSEIDON criteria

X Liu, J Xu, L Bi, P Liu, X Jiao - Frontiers in Endocrinology, 2021 - frontiersin.org
Background Poor ovarian response (POR) remains one of the most challenging conditions
in assisted reproduction technology. Previous studies seemed to indicate that growth …

A preliminary observation on efficacy of growth hormone on poor ovarian responders in IVF/ICSI cycles

J OU, W XING, LI Tao, J ZHU, W ZHU - Journal of Reproduction and …, 2016 - Elsevier
Objective To determine efficacy of gonadotropin (Gn) co-treated with growth hormone (GH)
on poor ovarian response (POR) patients undergoing in vitro fertilization/intracytoplasmic …

Effects of growth hormone supplementation on poor ovarian responders in assisted reproductive technology: a systematic review and meta-analysis

FT Liu, KL Hu, R Li - Reproductive Sciences, 2021 - Springer
To investigate whether additional growth hormone (GH) treatment can improve pregnancy
outcomes in poor ovarian responders (POR), this systematic review and meta-analysis is …

Outcomes of in vitro fertilization–embryo transfer in women with diminished ovarian reserve after growth hormone pretreatment

Y Chen, L Tao, Y Lin, X Li, C Ma - Gynecological Endocrinology, 2020 - Taylor & Francis
The study was to evaluate the in vitro fertilization–embryo transfer (IVF-ET) outcomes in
women with diminished ovarian reserve (DOR) after pretreatment with growth hormone …

[HTML][HTML] Effects of adjuvant growth hormone therapy on poor ovarian responders in assisted reproductive technology

S Zafardoust, S Ansaripor, A Karimi, H Hosseinirad… - Maedica, 2022 - ncbi.nlm.nih.gov
Objective: The present study aimed to evaluate the effect of adjuvant growth hormone (GH)
therapy in antagonist protocol aiming to improve ovarian response and clinical outcomes of …

[HTML][HTML] The Effect of Growth Hormone on the Clinical Outcomes of Poor Ovarian Reserve Patients Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection …

M Cai, L Gao, XY Liang, C Fang, Y Wu… - Frontiers in …, 2019 - frontiersin.org
The aim of this retrospective analysis is to explore whether growth hormone (GH)
pretreatment is beneficial for patients with poor ovarian reserve undertaking in vitro …

Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology

M Eftekhar, A Aflatoonian, F Mohammadian… - Archives of gynecology …, 2013 - Springer
Purpose The incidence of poor ovarian response in controlled ovarian stimulation (COH)
has been reported in 9–24% of IVF-ET cycles. Growth hormone augments the effect of …

[HTML][HTML] Reproductive outcomes of dual trigger therapy with GnRH agonist and hCG versus hCG trigger in women with diminished ovarian reserve: a retrospective …

K Chen, C Zhang, L Chen, Y Zhao, H Li - Reproductive Biology and …, 2024 - Springer
Background Diminished ovarian reserve (DOR) is one of the obstacles affecting the
reproductive outcomes of patients receiving assisted reproductive therapy. The purpose of …

[HTML][HTML] Comparative efficacy of different growth hormone supplementation protocols in improving clinical outcomes in women with poor ovarian response undergoing …

Z Xu, W Tong, Z Yang, H Zhang, X Chen - Scientific Reports, 2024 - nature.com
Growth hormone (GH) has a long-standing history of use as an adjunctive therapy in the
treatment of poor ovarian response (POR), but the optimal dosage and timing remains …